On March 5, Japan unveiled new NHI prices for the FY2024 drug price revision. A Jiho survey found that Tsumura, a specialist in Japanese Kampo herbal medicines, received an astonishing raise of over 24% in its drug prices on a…
HOME > COMMENTARY
COMMENTARY
-
COMMENTARY/Will It Be Possible to Eliminate Use of Multiple Antipsychotics in Massive Doses?
September 14, 2009
-
COMMENTARY/Establish Solid Criteria for Switching Ethical Drugs to OTC Status
September 14, 2009
-
COMMENTARY/Korosho to Embark on Japanese Version of Sentinel Initiative
September 7, 2009
-
COMMENTARY/Wholesalers Need to Analyze Causes of Their Failure
August 24, 2009
-
COMMENTARY/Hisamitsu Aims at Growth by Fusing Its and Noven's Technologies
August 24, 2009
-
COMMENTARY/Permitting MSs to Take MR Cert. Exam Offers New Business Opportunity to Wholesalers
August 3, 2009
-
COMMENTARY/Fair Profits Are Essential to Spread Regenerative Medicine
August 3, 2009
-
Hitech Drugs Open the Window to the Future- With Special Focus on Development and Marketing -(1)
July 20, 2009
-
Hitech Drugs Open the Window to the Future- With Special Focus on Development and Marketing -(2)
July 20, 2009
-
COMMENTARY/Global Pharmas Enhance Their Presence in Japan
July 13, 2009
-
COMMENTARY/Additional Price Cuts for Long-listed Original Drugs
June 29, 2009
-
COMMENTARY/Clinical Applications of ADCs Coming Closer to Reality
June 29, 2009
-
SURVEY/RLS Takes Almost Four Years before Being Diagnosed
June 22, 2009
-
COMMENTARY/JSHP to Promote Use of Generics
June 8, 2009
-
COMMENTARY/Combination Drugs Becoming a "Boom"
June 1, 2009
-
COMMENTARY/Clearer Criteria Needed for Patent Period Restoration
May 4, 2009
-
COMMENTARY/Why Does the Use of Generics Not Increase?
April 27, 2009
-
EMTs Allowed to Administer Epipen
April 27, 2009
-
COMMENTARY/Medway Data Falsification to Make Blood Product Self-Sufficiency Difficult
April 20, 2009
-
The First Round Results of GE Amlodipine (2)- Making No Surprise Moves Leads to Success -
April 6, 2009
ページ
Too often, recruiters are more clear on what a position will “do” rather than what it will “achieve”.Outlining tasks and responsibilities takes priority over goals and impact.But to attract top talent, you need to define and explain what success looks…
The Japanese health ministry on December 22 approved a batch of medicines for additional indications, including Otsuka Pharmaceutical’s atypical antipsychotic Rexulti (brexpiprazole) and Zenyaku Kogyo’s anti-CD20 antibody Rituxan (rituximab).Rexulti is now newly indicated for the treatment of depression and depressive…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…